Alliance Foundation Trials, Llc.
Clinical trials sponsored by Alliance Foundation Trials, Llc., explained in plain language.
-
Could adding immunotherapy after surgery keep lung cancer away?
Disease control Recruiting nowThis study tests whether adding an immunotherapy drug (durvalumab) to standard chemotherapy after surgery for early-stage small cell lung cancer helps keep the cancer from coming back. About 65 adults who had their lung cancer completely removed will receive this combination. The…
Phase: PHASE2 • Sponsor: Alliance Foundation Trials, LLC. • Aim: Disease control
Last updated May 26, 2026 05:49 UTC
-
New combo therapy offers hope for hard-to-treat endometrial cancer
Disease control Recruiting nowThis study tests whether combining targeted drugs with the immunotherapy atezolizumab can shrink tumors or slow cancer growth in people with recurrent or persistent endometrial cancer. About 148 participants whose cancer has returned after at least one prior treatment will be enr…
Phase: PHASE1, PHASE2 • Sponsor: Alliance Foundation Trials, LLC. • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
Money stress and cancer: can a simple monthly survey make a difference?
Knowledge-focused Recruiting nowThis study looks at whether asking people with advanced or metastatic cancer about their financial worries every month can improve their quality of life and reduce stress. About 1,000 adults who are getting cancer treatment that is not meant to cure them will take part. The goal …
Phase: NA • Sponsor: Alliance Foundation Trials, LLC. • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC